IA with TheraSorb ® column (Miltenyi) clinical trials

Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS

This study looks at a treatment called Immunoadsorption (IA) for people with ME/CFS, especially if it started after a COVID infection. It aims to see if IA helps improve symptoms and if certain blood markers can predict who will benefit most.